Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Stomatitis 3Head and Neck Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Pancreatic Neoplasms 1Oral Ulcer 1Esophagitis 1Carcinoma, Squamous Cell 1

Interventions

Fibroblast Growth Factor 7 5Cisplatin 4avasopasem manganese 3Water 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Injections 2sargramostim 1peppermint oil 1meclocycline 1dusquetide 1clazakizumab 1brilacidin 1anise oil 1Xylitol 1Whole-Body Irradiation 1Vincristine 1Transplantation Conditioning 1Transcutaneous Electric Nerve Stimulation 1Standard of Care 1Sorbic Acid 1Salts 1Saliva, Artificial 1Saline Solution 1RRx-001 1Practice Guidelines as Topic 1Poloxamer 1Phosphatidylinositol 3-Kinases 1Periodontal Debridement 1Methylene Blue 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Stomatitis × avasopasem manganese × Clear all
NCT03689712 2023-10-24

ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients

Galera Therapeutics, Inc.

Phase 3 Completed
455 enrolled 11 charts
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Stomatitis, Oral Ulcer

NCT04529850 2022-08-16

Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer

Galera Therapeutics, Inc.

Phase 2 Completed
38 enrolled 10 charts
Head & Neck

Head and Neck Neoplasms, Stomatitis

NCT02508389 2021-09-20

A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer

Galera Therapeutics, Inc.

Phase 2 Completed
223 enrolled 17 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡